3-TYP, a selective inhibitor of SIRT3, was obtained from Selleck Chemicals (Shanghai, China). Actinomycin D was purchased from APE-Bio (Houston, USA). TSA and NAM were from MedChemExpress LLC (Shanghai, China). The expressing plasmids of vIL-6-Flag and vFLIP-Flag were generated as previously described [24 (link),59 (link)]. The skeleton plasmid for lentiviral vectors vCyclin-Myc, SERBP1-HA/Myc, SIRTs-Myc and Lipt2-Flag was pCDH-CMV-MCS-EF1-copGFP (referred to as pCDH). The expressing plasmid of LANA-Flag was kindly provided by Dr. Ke Lan from Wuhan University. The small guide RNA sequences (sgRNAs) targeting SERBP1 and SIRT3 are listed in S1 Table. The control vector of all sgRNAs was Lenti-CRISPR-V2 (Lenti-V2 for short). All constructs were verified through DNA sequencing.
Free full text: Click here